About the Journal

Journal of Translational Medicine & Biopharmaceuticals is an open-access, peer-reviewed journal publishing high-quality research at the interface of basic discovery, clinical development, and biopharmaceutical innovation. The journal provides a multidisciplinary platform for scientists, clinicians, and industry professionals to share findings that accelerate the translation of laboratory insights into safe and effective therapies.

Each submission undergoes a thorough peer-review process conducted by members of the editorial board and a panel of expert reviewers. Authors are encouraged to adhere to the journal's detailed formatting and submission guidelines, which are designed to ensure efficient editorial processing.

Only original and unpublished research—whether experimental or theoretical—that is not under review elsewhere will be considered. Once accepted, articles are scheduled for publication in upcoming issues, depending on the editorial board's prioritization.

Journal of Translational Medicine & Biopharmaceuticals aims to integrate fundamental and applied research across preclinical models, clinical investigation, pharmaceutical sciences, and regulatory science. By fostering collaboration and rigorous knowledge dissemination, the journal contributes to innovations in drug, biologic, cell/gene therapy development, diagnostics, and precision medicine.